Patient from Indore flown to Mumbai for the treatment of green fungus

Doctors have informed that several cases with green fungus (aspergillus) have been reported during the second COVID-19 wave and there has been a rise in the number of patients too.

Patient from Indore flown to Mumbai for the treatment of green fungus

After identifying black, white and yellow fungus, doctors from Indore (Madhya Pradesh) have reported a case of green fungus, in a patient who had recovered from coronavirus (COVID-19) infection recently. Also known as Aspergillus infection, this fungal infection is said to affect sinus, lungs and blood. Doctors have informed that several such cases have increased in the last few days. The infeciton known as Aspergillosis is caused by mould which lives indoors and outdoors.

Reports stated that the  34-year-old patient was being treated at Indore-based Shri Aurobindo Institute of Medical Science and is now shifted to Mumbai for further treatment. He was airlifted on Monday, June 14, 2021. He suffered COVID-19 infection for two months and had recovered from the same, however, he returned with symptoms like bleeding nose, weakness and high fever. Test results revealed aspergillus infection, and he was soon admitted in the ICU at PD Hinduja Hospital in Mumbai.

Also Read: Black Fungus: 3 kids undergo eye removal surgery after getting infected

Earlier, five other COVID-19 patients in Mumbai were diagnosed with either aspergillosis and mucormycosis or both, and were offered treatment by specialists. Sharing more information about the cases, an infectious diseases expert at Global and Lilavati hospitals, Dr Vasant Nagvekar, told Mid-Day, “We are seeing rising cases of both green fungus, mucormycosis, and pneumocystis pneumonia (PCP) — another life-threatening fungal pneumonia, and cytomegalovirus infections with Covid-19. In some cases, we are seeing a combined infection.”

Besides above-mentioned symptoms, patients have also been reported with face numbness, tooth ache, orbital pain, among other conditions. Significant rise in this form of fungal infection has raised concerns among doctors and patients, as the trend has been observed clearly in the second COVID-19 wave. Aspergillus is observed to affect the lungs first, unlike the black fungus.

Also Read: Bombay HC Questions Centre Over Shortage of Mucormycosis Drug in Maharashtra

MumbaiLive would like to send you latest news updates